January 8, 2026
1:00 - 2:00 pm ET
$149 Includes Playback without Expiration
Please join us for a timely, practical discussion with Chris Van Dyck, Partner at Cogent Law Group, as he breaks down the federal government’s long-anticipated shift in how cannabis is treated—and what that shift could mean right now for banks and credit unions that serve cannabis-related businesses.
This session is designed for compliance, risk, lending, and business development leaders who need to translate “headline” changes into clear operational decisions. Chris will outline what’s likely ahead, what’s still uncertain, and how to position your institution to stay compliant while remaining competitive.
Chris will cover key strategies and considerations, including:
Timing and procedural milestones: To watch as rescheduling moves forward—and how to plan through uncertainty
BSA/AML and compliance impacts: What may change, what won’t, and where examiner expectations are likely to remain high
Risk framework updates: Re-evaluating enterprise and cannabis program risk assessments, policies, procedures, and controls
Lending implications: Revisiting underwriting standards, portfolio strategy, and credit policy as IRC 280E no longer applies (and how that can affect cash flow, DSCR, and tax-adjusted financials)
Customer communications: What you should be telling cannabis customers and members now to manage expectations and strengthen relationships
Business services & competition: Treasury/cash management, onboarding, product positioning, and how to compete effectively as more institutions enter the market
